Marcel Blommers
Company: Saverna Therapeutics
Job title: Chief Scientific Officer
Seminars:
Live Panel Q&A – Ask the Speakers your Burning Questions 4:15 pm
day: Day One
Revealing Fragment-Based Screening Approaches Using NMR Demonstrates the Druggability of Biologically Active RNA 3:35 pm
• Discuss how NMR-based fragment screening demonstrates the druggability of biologically active RNAs • Outlining how SMN2 splice modulators can enhance pre-mRNA association and rescue SMA mice • Evaluating the utility of fragment-screening library-NMR-based quality controlRead more
day: Day One